<p>HBM Holdings Ltd. has announced a significant increase in its expected profit for the year ended 31 December 2025. Based on preliminary unaudited management accounts, the company anticipates its profit to be in the range of approximately US$88 million to US$95 million, a sharp rise compared to a profit of about US$2.7 million recorded for the previous year. Additionally, total adjusted profit is projected to be between US$91 million and US$98 million, highlighting a substantial improvement in the company’s business performance for the period. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260204-12012725), on February 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

Reuters

SPDR S&P Biotech

Health Care Select Sector SPDR

iShares Global Healthcare

First Trust NYSE Arca Biotech Index Fd

iShares US Pharma

Invesco Biotechnology & Genome ETF

Invesco Nasdaq Biotechnology ETF

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

Ark Genomic Revolution ETF

Proshares UltraShort Nasdaq Biotech

VanEck Biotech ETF

ALPS Medical Breakthrough

Direxion S&P Biotech Bull 3X

VG Health

HBM Holdings Expects 2025 Profit to Surge to Up to US$95 Million